Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Hutson

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Expert Review of Anticancer Therapy|September 26, 2007
Safety and tolerability of sorafenib in clear-cell renal cell carcinoma: a Phase III overviewThomas E Hutson
Proceedings (Baylor University. Medical Center)|October 28, 2005
Renal cell carcinoma: diagnosis and treatment, 1994-2003Thomas E Hutson
The Oncologist|February 25, 2011
Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidenceThomas E Hutson
BJU International|April 4, 2008
Renal cell carcinoma: what does the future hold?Thomas E Hutson
Proceedings (Baylor University. Medical Center)|July 20, 2007
Targeted therapy for renal cell carcinoma: a new treatment paradigmThomas E Hutson
Expert Review of Anticancer Therapy|October 22, 2008
Sunitinib (SUTENT) for the treatment of metastatic renal cell carcinomaThomas E Hutson
American Journal of Clinical Oncology|April 8, 2006
New approaches in hormone refractory prostate cancerGuru Sonpavde, Thomas E Hutson
Expert Opinion on Biological Therapy|January 26, 2007
Recent advances in the therapy of renal cancerGuru Sonpavde, Thomas E Hutson
Clinical Genitourinary Cancer|November 7, 2009
Novel antiangiogenic agents in the treatment of refractory renal cell carcinomaGuru Sonpavde, Thomas E Hutson
The Lancet. Oncology|August 11, 2012
Difficulty in predicting survival in metastatic renal cancerTom Powles, Thomas E Hutson
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Expert Review of Anticancer Therapy|September 26, 2007
Safety and tolerability of sorafenib in clear-cell renal cell carcinoma: a Phase III overviewThomas E Hutson
Proceedings (Baylor University. Medical Center)|October 28, 2005
Renal cell carcinoma: diagnosis and treatment, 1994-2003Thomas E Hutson
The Oncologist|February 25, 2011
Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidenceThomas E Hutson
BJU International|April 4, 2008
Renal cell carcinoma: what does the future hold?Thomas E Hutson
Proceedings (Baylor University. Medical Center)|July 20, 2007
Targeted therapy for renal cell carcinoma: a new treatment paradigmThomas E Hutson
Expert Review of Anticancer Therapy|October 22, 2008
Sunitinib (SUTENT) for the treatment of metastatic renal cell carcinomaThomas E Hutson
American Journal of Clinical Oncology|April 8, 2006
New approaches in hormone refractory prostate cancerGuru Sonpavde, Thomas E Hutson
Expert Opinion on Biological Therapy|January 26, 2007
Recent advances in the therapy of renal cancerGuru Sonpavde, Thomas E Hutson
Clinical Genitourinary Cancer|November 7, 2009
Novel antiangiogenic agents in the treatment of refractory renal cell carcinomaGuru Sonpavde, Thomas E Hutson
The Lancet. Oncology|August 11, 2012
Difficulty in predicting survival in metastatic renal cancerTom Powles, Thomas E Hutson
Pageof 15